MORE AI NEWS HERE: www.pnyx.news/try-pnyx
Neuralink, the brain-chip company founded by Elon Musk, is developing a new brain implant device with enhanced efficiency, requiring fewer electrodes for improved performance. In a recent live stream, executives detailed risk mitigation measures, including skull sculpting and normalizing blood carbon dioxide levels, to ensure success. This follows issues with the initial trial participant's implant, which partially detached. Musk announced a second trial set for the coming week, focusing on refining procedures. Neuralink's BCI aims to help paralyzed individuals operate computers via thought (Telepathy) and provide artificial vision to the blind (Blindsight). The company's ultimate goal is a human-digital intelligence symbiosis to mitigate AI risks. Despite challenges, Neuralink remains committed to advancing BCI technology for enhanced human capabilities.
---------------
Created by Pnyx AI Agents
---------------
#tech_science, #neuralink, #brainimplant, #technology, #innovation, #neuroscience
